Inhibition of primary human T cell proliferation by Helicobacter pylori vacuolating toxin (VacA) is independent of VacA effects on IL-2 secretion

  1. Mark S. Sundrud*,,
  2. Victor J. Torres*,,
  3. Derya Unutmaz*,, and
  4. Timothy L. Cover*,,§,
  1. Departments of *Microbiology and Immunology and §Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232-2605; and Veterans Affairs Medical Center, Nashville, TN 37212
  1. Edited by Stanley Falkow, Stanford University, Stanford, CA (received for review March 3, 2004)

Abstract

Recent evidence indicates that the secreted Helicobacter pylori vacuolating toxin (VacA) inhibits the activation of T cells. VacA blocks IL-2 secretion in transformed T cell lines by suppressing the activation of nuclear factor of activated T cells (NFAT). In this study, we investigated the effects of VacA on primary human CD4+ T cells. VacA inhibited the proliferation of primary human T cells activated through the T cell receptor (TCR) and CD28. VacA-treated Jurkat T cells secreted markedly diminished levels of IL-2 compared with untreated cells, whereas VacA-treated primary human T cells continued to secrete high levels of IL-2. Further experiments indicated that the VacA-induced inhibition of primary human T cell proliferation was not attributable to VacA effects on NFAT activation or IL-2 secretion. We show here that VacA suppresses IL-2-induced cell-cycle progression and proliferation of primary human T cells without affecting IL-2-dependent survival. Through the analysis of a panel of mutant VacA proteins, we demonstrate that VacA-mediated inhibition of T cell proliferation requires an intact N-terminal hydrophobic region necessary for the formation of anion-selective membrane channels. Remarkably, we demonstrate that one of these mutant VacA proteins [VacA-Δ(6–27)] abrogates the immunosuppressive actions of wild-type VacA in a dominant-negative fashion. We suggest that VacA may inhibit the clonal expansion of T cells that have already been activated by H. pylori antigens, thereby allowing H. pylori to evade the adaptive immune response and establish chronic infection.

Footnotes

  • To whom correspondence may be addressed. E-mail: derya.unutmaz{at}vanderbilt.edu or timothy.l.cover{at}vanderbilt.edu.

  • M.S.S. and V.J.T. contributed equally to this work.

  • This paper was submitted directly (Track II) to the PNAS office.

  • Abbreviations: VacA, vacuolating toxin; NFAT, nuclear factor of activated T cells; CFSE, carboxy fluorescein diacetate succinimide ester; PMA, phorbol myristate acetate; CBA, cytometric bead array; PI, propidium iodide; Th, T helper.

« Previous | Next Article »Table of Contents